These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 22018135

  • 21. Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive.
    Pantoja M, Medeiros T, Baccarin MC, Morais SS, Bahamondes L, Fernandes AM.
    Contraception; 2010 Feb; 81(2):107-11. PubMed ID: 20103446
    [Abstract] [Full Text] [Related]

  • 22. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L.
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [Abstract] [Full Text] [Related]

  • 23. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [Abstract] [Full Text] [Related]

  • 24. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM.
    Int J Fertil Womens Med; 1998 Nov; 43(2):73-83. PubMed ID: 9609206
    [Abstract] [Full Text] [Related]

  • 25. [Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil].
    Yela DA, Monteiro IM, Bahamondes LG, Del Castillo S, Bahamondes MV, Fernandes A.
    Rev Assoc Med Bras (1992); 2006 Nov; 52(1):32-6. PubMed ID: 16622536
    [Abstract] [Full Text] [Related]

  • 26. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 27. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
    Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L.
    Chin Med J (Engl); 2013 Nov 06; 126(21):4043-7. PubMed ID: 24229671
    [Abstract] [Full Text] [Related]

  • 28. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
    Johnson CC, Burkman RT, Gold MA, Brown RT, Harel Z, Bruner A, Stager M, Bachrach LK, Hertweck SP, Nelson AL, Nelson DA, Coupey SM, McLeod A, Bone HG.
    Contraception; 2008 Apr 06; 77(4):239-48. PubMed ID: 18342646
    [Abstract] [Full Text] [Related]

  • 29. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P.
    Contraception; 2002 Jun 06; 65(6):407-10. PubMed ID: 12127638
    [Abstract] [Full Text] [Related]

  • 30. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May 06; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 31. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
    Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y.
    Contraception; 2011 Mar 06; 83(3):218-22. PubMed ID: 21310282
    [Abstract] [Full Text] [Related]

  • 32. Long-acting contraceptive options.
    Kaunitz AM.
    Int J Fertil Menopausal Stud; 1996 Mar 06; 41(2):69-76. PubMed ID: 8829701
    [Abstract] [Full Text] [Related]

  • 33. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
    Westhoff C.
    J Reprod Med; 1996 May 06; 41(5 Suppl):401-6. PubMed ID: 8725702
    [Abstract] [Full Text] [Related]

  • 34. A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate.
    Segall-Gutierrez P, Agarwal R, Ge M, Lopez C, Hernandez G, Stanczyk FZ.
    Eur J Contracept Reprod Health Care; 2013 Jun 06; 18(3):199-205. PubMed ID: 23530919
    [Abstract] [Full Text] [Related]

  • 35. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, Stager M, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Wolter K, Nelson A, Marshall S, Bachrach LK.
    Contraception; 2010 Apr 06; 81(4):281-91. PubMed ID: 20227543
    [Abstract] [Full Text] [Related]

  • 36. Changes in calcium metabolism and bone mineral density in new users of medroxyprogesterone acetate during the first year of use.
    Quintino-Moro A, Zantut-Wittmann DE, Silva Dos Santos PN, Silva CA, Bahamondes L, Fernandes A.
    Int J Gynaecol Obstet; 2019 Dec 06; 147(3):319-325. PubMed ID: 31479152
    [Abstract] [Full Text] [Related]

  • 37. Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up.
    dos Santos Pde N, Modesto WO, Dal'Ava N, Bahamondes MV, Pavin EJ, Fernandes A.
    Eur J Contracept Reprod Health Care; 2014 Dec 06; 19(6):432-8. PubMed ID: 25047227
    [Abstract] [Full Text] [Related]

  • 38. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec 06; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 39. Depot-medroxyprogesterone acetate contraception use among Salvadoran women: an in-depth analysis of attitudes and experiences.
    Cremer M, Ditzian L, April A, Peralta E, Klausner D, Podolsky R, Dierking E.
    J Womens Health (Larchmt); 2011 Nov 06; 20(11):1751-6. PubMed ID: 21823919
    [Abstract] [Full Text] [Related]

  • 40. Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.
    Walsh JS, Eastell R, Peel NF.
    Fertil Steril; 2010 Feb 06; 93(3):697-701. PubMed ID: 19013564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.